back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-24 12:24 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,200,000 vol $1,000 each |
$1,200,000 | |
| Filed 2023-05-01 13:52 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,200 vol $1,000 each |
||
| Filed 2023-05-01 13:52 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,200 vol $1,000 each |
$1,200 | |
| Filed 2023-05-01 13:51 Tx date 2019-09-24 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-17 17:20 Tx date 2022-10-14 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+5,000 vol $0.25 each |
21,738,919 | |
| Filed 2022-10-13 13:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-15,478 vol |
644 | |
| Filed 2022-09-08 12:39 Tx date 2022-09-08 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+12,000 vol $0.23 each |
21,733,919 | |
| Filed 2022-08-30 11:10 Tx date 2022-08-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,224
+12,400 vol $0.26 each |
21,721,919 | |
| Filed 2022-04-25 13:33 Tx date 2022-04-22 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,000,000
+20,000,000 vol $0.15 each |
38,420,000 | |
| Filed 2022-04-25 13:32 Tx date 2022-04-22 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+10,000,000 vol |
10,000,000 | |
| Filed 2022-04-25 13:30 Tx date 2019-09-24 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-25 13:27 Tx date 2022-04-22 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000,000
+20,000,000 vol $0.15 each |
||
| Filed 2022-03-29 12:40 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$4,117,553
+5,718,824 vol $0.72 each |
5,718,824 | |
| Filed 2022-03-29 12:40 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:39 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,431,294
+5,718,824 vol $0.60 each |
21,709,519 | |
| Filed 2022-02-22 13:47 Tx date 2022-02-22 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000,000
+5,000,000 vol $0.20 each |
18,420,000 | |
| Filed 2022-01-24 12:42 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-24,242 vol |
16,122 | |
| Filed 2021-12-30 21:27 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
40,364 | |
| Filed 2021-10-27 16:25 Tx date 2021-10-25 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,534
+5,000 vol $0.3068 each |
13,400,000 | |
| Filed 2021-10-27 10:44 Tx date 2021-10-26 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,729
+20,000 vol $0.2865 each |
13,415,000 | |
| Filed 2021-08-26 14:18 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,516
+28,500 vol $0.369 each |
13,395,000 | |
| Filed 2021-08-26 14:18 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+1,500 vol $0.36 each |
13,366,500 | |
| Filed 2021-08-26 14:17 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$356.20
+1,000 vol $0.3562 each |
13,365,000 | |
| Filed 2021-08-26 14:17 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.25
+2,500 vol $0.3601 each |
13,364,000 | |
| Filed 2021-08-26 14:15 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,371
+17,500 vol $0.3641 each |
13,361,500 | |
| Filed 2021-08-26 14:15 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$926.00
+2,500 vol $0.3704 each |
13,344,000 | |
| Filed 2021-08-26 14:14 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$930.00
+2,500 vol $0.372 each |
13,341,500 | |
| Filed 2021-08-26 14:14 Tx date 2021-08-25 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,560
+4,000 vol $0.39 each |
13,339,000 | |
| Filed 2021-08-26 14:13 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,552
+4,500 vol $0.3451 each |
13,335,000 | |
| Filed 2021-08-26 14:13 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,051
+14,500 vol $0.3484 each |
13,330,500 | |
| Filed 2021-08-26 14:12 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$352.20
+1,000 vol $0.3522 each |
13,316,000 | |
| Filed 2021-08-26 14:11 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,571
+4,500 vol $0.3493 each |
13,315,000 | |
| Filed 2021-08-26 14:11 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,509
+10,000 vol $0.3509 each |
13,310,500 | |
| Filed 2021-08-26 14:10 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,108
+25,500 vol $0.3572 each |
13,300,500 | |
| Filed 2021-08-26 14:10 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,640
+34,500 vol $0.3374 each |
13,275,000 | |
| Filed 2021-08-26 14:09 Tx date 2021-08-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,473
+30,000 vol $0.3491 each |
13,240,500 | |
| Filed 2021-01-28 17:11 Tx date 2021-01-28 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,973
+10,500 vol $0.4737 each |
13,210,500 | |
| Filed 2021-01-08 17:03 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,200,000 | ||
| Filed 2021-01-08 16:47 Tx date 2020-06-30 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+13,147,200 vol |
||
| Filed 2021-01-08 16:46 Tx date 2020-06-23 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,147,200 vol |
||
| Filed 2021-01-08 16:46 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+13,134,000 vol |
||
| Filed 2021-01-08 16:46 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+26,000 vol |
||
| Filed 2021-01-08 16:46 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+40,000 vol |
||
| Filed 2020-12-09 19:23 Tx date 2020-06-30 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+13,147,200 vol |
||
| Filed 2020-12-09 19:23 Tx date 2020-06-23 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,147,200 vol |
||
| Filed 2020-12-09 19:21 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+13,134,000 vol |
||
| Filed 2020-12-09 19:16 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+26,000 vol |
||
| Filed 2020-12-09 19:12 Tx date 2020-01-29 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+26,000 vol |
||
| Filed 2020-12-09 19:12 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+40,000 vol |
||
| Filed 2020-12-09 19:09 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-17 12:07 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
33,364 | |
| Filed 2020-12-09 19:23 Tx date 2020-06-30 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+13,147,200 vol |
13,200,000 | |
| Filed 2020-12-09 19:23 Tx date 2020-06-23 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,147,200 vol |
52,800 | |
| Filed 2020-12-09 19:21 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+13,134,000 vol |
13,200,000 | |
| Filed 2020-12-09 19:16 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+26,000 vol |
66,000 | |
| Filed 2020-12-09 19:12 Tx date 2020-01-29 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+26,000 vol |
||
| Filed 2020-12-09 19:12 Tx date 2020-01-09 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+40,000 vol |
40,000 | |
| Filed 2020-12-09 19:09 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Garner, William James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-02 09:03 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-843,636 vol |
26,364 | |
| Filed 2020-01-20 18:57 Tx date 2020-01-12 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
870,000 | |
| Filed 2019-01-16 Tx date 2019-01-14 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
835,000 | |
| Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,800
-10,000 vol $0.88 each |
82,786 | |
| Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,900
-10,000 vol $0.89 each |
72,786 | |
| Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,828.80
-29,786 vol $0.80 each |
0 | |
| Filed 2018-08-31 Tx date 2018-08-29 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-10,000 vol $0.86 each |
62,786 | |
| Filed 2018-08-31 Tx date 2018-08-27 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,600
-10,000 vol $0.86 each |
92,786 | |
| Filed 2018-08-31 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,730
-33,000 vol $0.81 each |
29,786 | |
| Filed 2018-08-24 Tx date 2018-08-24 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-20,000 vol $0.84 each |
132,786 | |
| Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,600
-40,000 vol $0.74 each |
274,286 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-10,000 vol $0.81 each |
152,786 | |
| Filed 2018-08-24 Tx date 2018-08-24 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,600
-30,000 vol $0.82 each |
102,786 | |
| Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-385.00
-500 vol $0.77 each |
243,786 | |
| Filed 2018-08-24 Tx date 2018-08-21 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,205
-8,500 vol $0.73 each |
235,286 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,015
-19,500 vol $0.77 each |
192,786 | |
| Filed 2018-08-24 Tx date 2018-08-22 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,910
-21,500 vol $0.74 each |
212,286 | |
| Filed 2018-08-24 Tx date 2018-08-22 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,095
-1,500 vol $0.73 each |
233,786 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-20,000 vol $0.80 each |
172,786 | |
| Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,200
-20,000 vol $0.76 each |
244,286 | |
| Filed 2018-08-24 Tx date 2018-08-20 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-10,000 vol $0.75 each |
264,286 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,800
-10,000 vol $0.78 each |
162,786 | |
| Filed 2018-05-22 Tx date 2018-05-18 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,000
-200,000 vol $0.13 each |
800,000 | |
| Filed 2018-05-22 Tx date 2018-05-18 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,000
+200,000 vol $0.13 each |
314,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,000
-5,000 vol $2.20 each |
294,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-73,584
-33,600 vol $2.19 each |
299,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,342
-12,600 vol $2.17 each |
332,886 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,600
-20,000 vol $2.13 each |
345,486 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-61,056
-28,800 vol $2.12 each |
365,486 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,000
-20,000 vol $2.10 each |
394,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,700
-10,000 vol $2.27 each |
204,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,100
-10,000 vol $2.41 each |
114,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,600
-20,000 vol $2.38 each |
124,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,400
-10,000 vol $2.34 each |
144,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,300
-10,000 vol $2.33 each |
154,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,200
-10,000 vol $2.32 each |
164,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,003
-1,300 vol $2.31 each |
174,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,010
-18,700 vol $2.30 each |
175,586 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,900
-10,000 vol $2.29 each |
194,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,798
-12,300 vol $2.26 each |
214,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,750
-27,000 vol $2.25 each |
226,586 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-45,248
-20,200 vol $2.24 each |
253,586 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,115
-500 vol $2.23 each |
273,786 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,200
-10,000 vol $2.22 each |
274,286 | |
| Filed 2018-01-08 Tx date 2018-01-08 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,100
-10,000 vol $2.21 each |
284,286 | |
| Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,100
-10,000 vol $0.41 each |
414,286 | |
| Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,252.50
-10,500 vol $0.405 each |
424,286 | |
| Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,800
-39,500 vol $0.40 each |
434,786 | |
| Filed 2017-10-20 Tx date 2017-10-19 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,865
-53,500 vol $0.39 each |
474,286 | |
| Filed 2017-10-16 Tx date 2017-10-13 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,990
-6,500 vol $0.46 each |
527,786 | |
| Filed 2017-10-16 Tx date 2017-10-12 |
$IN
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,800
-30,000 vol $0.46 each |
534,286 | |
| Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,555
-129,500 vol $0.29 each |
564,286 | |
| Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,097.50
-10,500 vol $0.295 each |
693,786 | |
| Filed 2017-08-22 Tx date 2017-08-22 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-10,000 vol $0.30 each |
704,286 | |
| Filed 2017-07-27 Tx date 2017-07-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-53,571.45
-357,143 vol $0.15 each |
0 | |
| Filed 2017-07-27 Tx date 2017-07-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+357,143 vol |
714,286 | |
| Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+357,143 vol |
357,143 | |
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,000
+357,143 vol $0.07 each |
357,143 | |
| Filed 2017-04-27 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+357,143 vol $0.07 each |
||
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-14 Tx date 2016-06-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$130,000
+1,000,000 vol $0.13 each |
||
| Filed 2016-09-14 Tx date 2016-07-28 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,000
+357,143 vol $0.07 each |
1,357,143 | |
| Filed 2016-09-14 Tx date 2016-06-10 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$130,000
+1,000,000 vol $0.13 each |
||
| Filed 2016-09-14 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2016-09-14 Tx date 2016-06-13 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|